Correlation of Glomerular Size With Donor-Recipient Factors and With Response to Injury.
Correlation of Glomerular Size With Donor-Recipient Factors and With Response to Injury.
复制标题
DOI:
10.1097/tp.0000000000003570
复制
发表时间:
2021-11-01
期刊:
影响因子:
6.2
通讯作者:
Matas AJ
中科院分区:
文献类型:
--
作者:
Grande JP;Helgeson ES;Matas AJ
Glomerular size in renal allografts is impacted by donor-recipient factors and response to injury. In serial biopsies of patients with well-functioning grafts, increased glomerular size correlates with better survival. However, no previous study has addressed association of glomerular size at the time of a for-cause biopsy and clinical/histopathologic markers of injury, or effect on long term graft outcome. Two cohorts of kidney transplant recipients enrolled in the Deterioration of Kidney Allograft Function (DeKAF) study were evaluated: The Prospective Cohort (PC, n=581): Patients undergoing first for cause kidney biopsy (KTxBx) 1.7±1.4 (mean ±SD) years posttransplant; and the Cross sectional Cohort (CSC, n=446): patients developing new-onset renal function deterioration 7.7 ± 5.6 years posttransplant . Glomerular planar surface area and diameter were measured on all glomeruli containing a vascular pole. KTxBx were read centrally in a blinded fashion according to Banff criteria. Glomerular area was significantly higher in the CSC than the PC; time from transplant to indication biopsy was associated with glomerular area in both cohorts (p-values ≤0.001). Glomerular area was associated with indices of microvascular inflammation (glomerulitis, peritubular capillary infiltrates; p-values ≤0.001) and segmental glomerulosclerosis (p-value <0.0001). In the CSC, higher glomerular area was associated with higher eGFR (p-value≤0.001) and increased graft survival after accounting for microvascular inflammation (adjusted hazard ratio =0.967; 95% CI: 0.948 to 0.986; hazard ratio in biopsies without evidence of diabetes or AMR=0.919, 95% CI: 0.856 to 0.987). Glomerular size is associated with histopathologic features present at the time of indication biopsy and with increased graft survival in the CSC.